For people with Parkinson's disease, higher physical activity may protect two things at once: mobility and mind. A study published October 7 in the journal Neurology found that patients with greater activity levels showed slower worsening of movement symptoms and slower declines in thinking and memory. Study author Dong-Woo Ryu of the University of Cincinnati in Ohio said previous research had linked activity to movement symptoms, but the new work suggests "dual benefits" — associations on both the motor and cognitive tracks.
294 People, 7 Years: The Most Active Declined Slowest
After adjusting for age, sex, and disease duration, the high-activity group showed slower cognitive decline and slower motor worsening than the low group. All three activity measures — total time, total volume, and vigorous time — pointed the same way.
The Official Line: Association, Not Causation, and Small Gaps
Ryu himself cooled the takeaway. He said the potential benefits may depend on "how long they stay active and whether they continue exercising over time," and that the between-group differences were small, possibly becoming more meaningful over longer periods. Because participants generally had good cognition at the start, he urged cautious interpretation and more research.
The limitations are plain: activity was self-reported and may be inaccurate; and as an observational study, it shows association only. It cannot prove that exercise slows progression — it is equally possible that people with milder disease simply move more.
Not the First: The Exercise Evidence Chain Keeps Growing
What It Means for Patients and Families
Parkinson's is a progressive brain disorder; movement and cognitive problems gradually erode independence. No drug has been proven to slow its course. If exercise can drag on both decline curves at once, it is one of the few interventions patients control themselves.
For clinicians, the study supports putting an "exercise prescription" higher on the agenda — not vague advice to move more, but help finding an intensity and rhythm the patient can sustain for years. Brisk walking, swimming, gardening, and housework all count; persistence is the point. For families, building a regular activity routine with the patient may beat buying supplements.
Don't Jump Ahead: Randomized Trials Come Next
The honest next step is randomized controlled trials: assign patients to different exercise regimens and see whose decline is slower years later — the only route toward causation. Open questions include dose (is eight hours a week a threshold, or is more better?) and safety (is vigorous exercise safe for everyone?).
Until then, the safest reading: exercise will not cure Parkinson's, but the evidence that it may be one of the cheapest ways to slow decline keeps piling up. Moving beats sitting — true for a 66-year-old patient, and for everyone else too.
